Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A challenging case of limb autoamputation.

Rheumatology (Oxford, England)·2025
Same author

Differences and Similarities Between Children and Adults With Rhupus Syndrome.

International journal of rheumatic diseases·2025
Same author

Extreme Phenotypic Variation in Siblings with Identical Homozygous Mutations Causing ADA2 Deficiency: A Case Series

Turkish journal of haematology : official journal of Turkish Society of Haematology·2025
Same author

Assessing cognitive functions in non-neuropsychiatric childhood systemic lupus erythematosus: Cross-sectional study.

Journal of psychosomatic research·2025
Same author

Transition of patients with systemic lupus erythematosus from pediatric to adult-oriented rheumatology care.

Turkish journal of medical sciences·2024
Same author

Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals.

Pediatric rheumatology online journal·2024
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Pediatric onset Behçet disease.

Seza Ozen1

  • 1Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey. sezaozen@hacettepe.edu.tr

Current Opinion in Rheumatology
|July 10, 2010
PubMed
Summary
This summary is machine-generated.

Behçet disease, a challenging vasculitis, is increasingly diagnosed in children. Understanding its genetic factors and adapting adult treatment strategies are crucial for managing this rare pediatric condition.

Related Experiment Videos

Last Updated: Jun 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Area of Science:

  • Pediatric Rheumatology
  • Vasculitis Research
  • Genetics of Autoimmune Diseases

Background:

  • Behçet disease presents unique challenges in pediatric rheumatology due to varied symptoms and unpredictable relapses.
  • Limited evidence-based data exists for pediatric Behçet disease treatment, necessitating a better understanding of its scope and pathogenesis.

Purpose of the Study:

  • To review current understanding of Behçet disease epidemiology and clinical features in children.
  • To explore genetic associations and their role in Behçet disease pathogenesis.
  • To evaluate available treatment strategies for pediatric Behçet disease, drawing from adult data.

Main Methods:

  • Review of recent epidemiological and genetic studies on Behçet disease.
  • Analysis of literature focusing on childhood Behçet disease, particularly ocular manifestations.
  • Evaluation of adult treatment recommendations for ocular and systemic involvement.

Main Results:

  • Behçet disease is more prevalent than previously thought, with ongoing research into genetic factors via genome-wide association studies.
  • Recent research on childhood Behçet disease highlights a significant focus on eye diseases.
  • Adult treatment strategies for various organ involvements, including ocular manifestations, are being reviewed alongside limited pediatric reports.

Conclusions:

  • Epidemiological data and clinical features aid in understanding Behçet disease extent, emphasizing differences in pediatric presentation.
  • Genetic associations offer potential insights into pathogenesis and treatment development.
  • Due to insufficient pediatric data, adapting adult treatment strategies is currently necessary for managing childhood Behçet disease.